help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ziegler, T. R.
Right arrow Articles by Wilmore, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ziegler, T. R.
Right arrow Articles by Wilmore, D. W.

Journal of Clinical Endocrinology & Metabolism, Vol 74, 865-873, Copyright © 1992 by Endocrine Society


ARTICLES

Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double-blind, randomized controlled study

TR Ziegler, JL Rombeau, LS Young, Y Fong, M Marano, SF Lowry and DW Wilmore
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215.

This multicenter, randomized, double-blind study was performed to investigate whether recombinant GH improves the efficacy of total parenteral nutrition (TPN). Fifteen stable patients requiring parenteral feeding due to gastrointestinal/pancreatic disease were studied. Constant maintenance TPN providing approximately 30 kcal/kg day and approximately 1.6 g protein/kg.day was administered during an initial 7-day baseline period. After randomization, daily sc injections of saline (control, n = 9) or GH (10 mg/day, n = 6) were administered a 14-day treatment period as nutrient intake remained constant. Elemental balances for nitrogen (N), potassium (K), phosphorus (P), and sodium (Na) were determined daily and serial blood indices, vital signs, and other clinical parameters were monitored. Nutrient balances approached equilibrium during the baseline week in both groups. With GH administration, a significant increase in N, K, and P balance occurred; in contrast, nutrient balances did not change significantly from baseline values in control patients. The cumulative change (delta) in nutrient balances from the baseline week was also significantly greater in the GH-treated patients (delta N: control+2 +/- 7 g vs. GH+36 +/- 6. g, P less than 0.005; delta K:+57 +/- 45 mmol vs.+199 +/- 19 mmol, P less than 0.03; delta P: -27 +/- 30 mmol vs. +91 +/- 69 mmol, P less than 0.02). Plasma insulin-like growth factor-I concentrations rose 5- fold and serum cholesterol rose slightly with GH; no other significant change in group mean blood values occurred. One patient receiving GH and chronic prednisone therapy developed moderate hyperglycemia and mild peripheral edema; no other deleterious effects attributable to GH were observed. GH was well tolerated and significantly enhanced nutrient retention compared to standard parenteral feeding alone. GH improves the efficacy of parenteral nutrient utilization in patients requiring TPN.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
B. D. FREEMAN, R. L. DANNER, S. M. BANKS, and C. NATANSON
Safeguarding Patients in Clinical Trials with High Mortality Rates
Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 190 - 192.
[Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
J. S. Scolapio
Effect of Growth Hormone, Glutamine, and Diet on Body Composition in Short Bowel Syndrome: A Randomized, Controlled Study
JPEN J Parenter Enteral Nutr, November 1, 1999; 23(6): 309 - 313.
[Abstract] [PDF]


Home page
NEJMHome page
J. Takala, E. Ruokonen, N. R. Webster, M. S. Nielsen, D. F. Zandstra, G. Vundelinckx, and C. J. Hinds
Increased Mortality Associated with Growth Hormone Treatment in Critically Ill Adults
N. Engl. J. Med., September 9, 1999; 341(11): 785 - 792.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. Corcoran and S. Grinspoon
Treatments for Wasting in Patients with the Acquired Immunodeficiency Syndrome
N. Engl. J. Med., June 3, 1999; 340(22): 1740 - 1750.
[Full Text] [PDF]


Home page
EndocrinologyHome page
E. Svanberg, L. Powell-Braxton, C. Ohlsson, H. Zachrisson, and K. Lundholm
The Role of the Growth Hormone/Insulin-Like Growth Factor I Axis in Stimulation of Protein Synthesis in Skeletal Muscles Following Oral Refeeding
Endocrinology, December 1, 1998; 139(12): 4906 - 4910.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
E. Svanberg
Insulin-Like Growth Factor 1 Inhibits Degradation and Improves Retention of Protein in Hindlimb Muscle of Lambs
JPEN J Parenter Enteral Nutr, March 1, 1997; 21(2): 115 - 116.
[Abstract] [PDF]


Home page
NEJMHome page
W. W. Souba
Nutritional Support
N. Engl. J. Med., January 2, 1997; 336(1): 41 - 48.
[Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
T. R. Ziegler
Growth Hormone Treatment Improves Serum Lipids and Lipoproteins in Adults With Growth Hormone Deficiency R. C. CUNEO, F. SALOMON, G. F. WATTS, ET AL Metabolism 42:1519-1523, 1993
JPEN J Parenter Enteral Nutr, November 1, 1994; 18(6): 558 - 559.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society